G2M Appoints Diagnostics Pioneer John Bishop, Former Cepheid CEO, to Its Advisory Board
In a strategic move set to bolster its global ambitions in the in-vitro diagnostics (IVD) space, Genes2Me (G2M), a fast-rising […]
In a strategic move set to bolster its global ambitions in the in-vitro diagnostics (IVD) space, Genes2Me (G2M), a fast-rising […]
Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer care, hasannounced the […]